Diantha Duvall
Director of Finance/CFO at CURIS, INC.
Net worth: 9 351 $ as of 30/04/2024
Diantha Duvall active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CURIS, INC. | Comptroller/Controller/Auditor | 05/08/2022 | - |
| Director of Finance/CFO | 05/08/2022 | - | |
| Treasurer | 05/08/2022 | - | |
| Corporate Officer/Principal | 26/07/2022 | 05/08/2022 | |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director/Board Member | 09/08/2021 | - |
Career history of Diantha Duvall
Former positions of Diantha Duvall
| Companies | Position | Start | End |
|---|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 05/03/2019 | 01/07/2022 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 01/02/2017 | 01/01/2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01/02/2015 | 01/01/2017 |
| MERCK & CO., INC. | Director/Board Member | 01/05/2009 | 01/01/2015 |
Training of Diantha Duvall
| Northeastern University | Graduate Degree |
| Colby College | Undergraduate Degree |
Statistics
International
| United States | 9 |
Operational
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| BIOGEN INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| CURIS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
- Stock Market
- Insiders
- Diantha Duvall
- Experience
